News
-
STA moves to new payment model
- 15 Mar 2021
Six funding knockbacks prompts Aussie company to rethink access, leading to a potentially new way of funding health innovations.
Read more -
‘Melanoma Man’ in new fight
- 15 Mar 2021
Melanoma survivor Jay Allen was awarded an Order of Australia in January for raising awareness of the cancer but now the father of six is facing another battle.
Read more -
Chiesi tries to broaden PBAC’s view
- 08 Mar 2021
Attempt to include carer costs in economic modelling for cannabis-derived drug not positively received.
Read more -
Aussie sponsor hits back at PBAC
- 08 Mar 2021
‘Disappointed’ at being pushed into a Risk Sharing Agreement for low-cost, Aussie-made product.
Read more -
Leaders prep for Zimmerman showdown
- 08 Mar 2021
Eight pharma executives will face the committee this week.
Read more -
Movement on Abilify clawback case
- 05 Mar 2021
As Plavix case went before the Full Federal Court, the Abilify case also inched forward.
Read more -
Aussie CAR-T maker builds top talent
- 04 Mar 2021
US pharma commercialisation expert joins newly ASX-listed Chimeric Therapeutics.
Read more -
PBS waitlist slims ahead of March meet
- 03 Mar 2021
EXCLUSIVE: Late 2020 PBS dump saw the waitlist slim down, although more than one in 10 recommendations fails to progress to listing.
Read more